Senores Pharmaceutic - Quaterly Results

The total revenue hovered 199.90% to Rs. 287.60 millions for the December 2025 quarter as against Rs. 95.90 millions during the corresponding quarter last year.The Net Profit of the company reported a remarkable increase of 147.66% to Rs. 26.50  millions  from Rs. 10.70 millions in previous same quarter.Operating profit surged to 88.50 millions from the corresponding previous quarter of 47.70 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202512	202412	% Var	202512	202412	% Var	202503	202403	% Var
Sales	287.60	95.90	199.90	839.10	267.00	214.27	385.40	340.10	13.32
Other Income	97.80	71.90	36.02	295.30	127.30	131.97	219.90	68.40	221.49
PBIDT	88.50	47.70	85.53	289.70	81.90	253.72	147.10	67.80	116.96
Interest	17.50	27.00	-35.19	50.90	41.80	21.77	65.20	27.10	140.59
PBDT	71.00	20.70	243.00	238.80	40.10	495.51	81.90	40.70	101.23
Depreciation	35.80	7.50	377.33	91.10	18.00	406.11	30.80	20.40	50.98
PBT	35.20	13.20	166.67	147.70	22.10	568.33	51.10	20.30	151.72
TAX	8.70	2.50	248.00	29.90	5.30	464.15	14.20	12.20	16.39
Deferred Tax	3.10	-0.30	-1133.33	10.30	-4.40	-334.09	-0.30	-1.40	-78.57
PAT	26.50	10.70	147.66	117.80	16.80	601.19	36.90	8.10	355.56
Equity	460.50	460.50	0.00	460.54	460.50	0.01	460.40	305.10	50.90
PBIDTM(%)	30.77	49.74	-38.13	34.53	30.67	12.55	38.17	19.94	91.46